Edition:
United Kingdom

Athenex Receives Positive Feedback From FDA On The Design Of Phase III Clinical Trial For Oraxol


Tuesday, 16 Jan 2018 

Jan 16 (Reuters) - Athenex Inc ::ATHENEX RECEIVES POSITIVE FEEDBACK FROM FDA ON THE DESIGN OF PHASE III CLINICAL TRIAL FOR ORAXOL.ATHENEX INC - SECOND INTERIM ANALYSIS OF ORAXOL PHASE III CLINICAL STUDY BASED ON 180 EVALUABLE PATIENTS IS PLANNED FOR MIDDLE OF 2018. 

Related Company News

Company Quote

11.06
-0.2 -1.78%
18 Apr 2019